✦ LIBER ✦

Prophylactic i.v. Igs in patients with a high risk for CMV after allo-SCT

✍ Scribed by Schmidt-Hieber, M; Schwarck, S; Stroux, A; Thiel, E; Ganepola, S; Uharek, L; Blau, I W

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A415 RIC allo-SCT for Patients with High

✍ Mohty, M; Milpied, N; Lioure, B; Yakoub-Agha, I; Bourhis, JH; Quoc-Hung, L; Nico 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 100 KB

Increased risk for invasive aspergillosi

✍ Gil, L; Kozlowska-Skrzypczak, M; Mol, A; Poplawski, D; Styczynski, J; Komarnicki 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 139 KB

Calcineurin inhibitor-free GVHD prophyla

✍ Schleuning, M; Judith, D; Jedlickova, Z; Stübig, T; Heshmat, M; Baurmann, H; Sch 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 152 KB

Impact of cytogenetics risk on outcome a

✍ Chevallier, P; Labopin, M; Milpied, N; Cornelissen, J J; Blaise, D; Petersen, E; 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 303 KB

Prophylactic implantation of cardioverte

✍ Kristen, Arnt V.; Dengler, Thomas J.; Hegenbart, Ute; Schonland, Stefan O.; Gold 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Impact of Cytogenetics Risk on Outcome A

✍ M. Mohty; M. Labopin; N. Milpied; J.J. Cornelissen; D. Blaise; E. Petersen; N. T 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 59 KB